www.perpetualcommotion.com
"Give with a free hand, but give only your own."
-- J.R.R. Tolkien The Children of Hurin
- Liver -
General Information:
Names:
Wikipedia entry:
Dr. Ray Shahelien entry:
********************************************************************************************
Observations:
Liver
See also C-reactive protein (CRP)
Gleevec
Liver,
Not Brain, May Be Origin of Alzheimer’s Plaques
ScienceDaily
(Mar.
3, 2011) — Unexpected results from a Scripps Research Institute
and ModGene, LLC study could completely alter scientists' ideas
about Alzheimer's disease -- pointing to the liver instead of
the brain as the source of the "amyloid" that deposits as brain
plaques associated with this devastating condition. The findings
could offer a relatively simple approach for Alzheimer's
prevention and treatment... The mice were injected with Gleevec
twice a day for seven days; then plasma and brain tissue were
collected, and the amount of beta amyloid in the blood and brain
was measured. The findings: the
drug dramatically reduced beta amyloid not only in the blood,
but also in the brain where the drug cannot penetrate.
Thus, an appreciable portion of brain amyloid must originate
outside of the brain, and imatinib represents a candidate for
preventing and treating Alzheimer's...
http://www.sciencedaily.com/releases/2011/03/110303134435.htm
J.
Gregor Sutcliffe, Peter B. Hedlund, Elizabeth A. Thomas, Floyd
E. Bloom, Brian S. Hilbush. Peripheral
reduction
of β-amyloid is sufficient to reduce brain β-amyloid:
Implications for Alzheimer's disease. Journal of Neuroscience Research,
March 3, 2011 DOI: 10.1002/jnr.2260
Peripheral reduction of
β-amyloid is sufficient to reduce brain β-amyloid:
implications for Alzheimer's disease.
Sutcliffe JG, Hedlund PB, Thomas EA, Bloom FE, Hilbush BS.
J
Neurosci Res. 2011 Jun;89(6):808-14. doi: 10.1002/jnr.22603.
Epub 2011 Mar 3.
Source:
Department of Molecular Biology, The Scripps Research Institute,
10550 N. Torrey Pines Rd., La Jolla, CA 92037, USA.
gregorsutcliffe@aol.com
Abstract
Three loci that modify β-amyloid (Aβ) accumulation and
deposition in the brains of a mouse model of Alzheimer's disease
have been previously described. One encompasses the Psen2 gene
encoding presenilin 2, a component of the γ-secretase activity
responsible for generating Aβ by proteolysis. We show that the
activity of mouse Psen2, as measured by levels of mRNA
accumulation, unexpectedly is heritable in the liver but not the
brain, suggesting liver as the origin of brain Aβ deposits.
Administration of STI571, a cancer therapeutic that does not
cross the blood-brain barrier, reduced accumulation of Aβ in
both the blood and the brain, confirming brain Aβ's peripheral
origin and suggesting that STI571 and related compounds might
have therapeutic/prophylactic value in human Alzheimer's
disease. The genes Cib1 and Zfhx1b reside within the other
modifier loci and also exhibit heritable expression in the
liver, suggesting that they too contribute to Aβ accumulation.
Comment in
From the
liver to the blood-brain barrier: an interconnected system
regulating brain amyloid-β levels. [J Neurosci Res.
2011]
PMID: 21374699 [PubMed]
http://www.ncbi.nlm.nih.gov/pubmed/21374699
********************************************************************************************
Known sources:
********************************************************************************************
Natural sources:
********************************************************************************************
References:
********************************************************************************************
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Home
Preface Brain Failure Notes Notes II
References pg. 1 References pg. 2
Nutritional Alternatives
Patricia's Protocol
Tauopathy
Discussion
Forum
Correspondence Newsletters Poems Memory Enhancement
Click to join tauopathies
********************************************************************************************
Questions or comments,
contact "perpetualcommotion.com" at gmail.com
Updated: July 2, 2012
Inception: July 2, 2012